Cash figures as of 2025-06-30. Database snapshot: 2026-09-21.
Price history
Loading RGC daily closes…
Loading price history…
Pipeline assets
TCM formula candidate
Stage not disclosed · ActiveModality: standardized liquid-based traditional Chinese medicine formula
Indications
attention deficit hyperactivity disorder(Stage not disclosed)
autism spectrum disorder(Stage not disclosed)
Status note Early-stage R&D; second efficacy trial in ADHD and ASD in Hong Kong ongoing as of the 20-F filing. Proprietary Chinese medicine registrations in Hong Kong planned. Formula not named in excerpts.
Per-asset detail extracted from the 20-F filed 2025-10-31. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.